U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07147621) titled 'Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies' on Aug. 05.
Brief Summary: Chemotherapy-induced cognitive disorders, such as memory problems, slowness of execution, inability to concentrate, and language difficulties, are sequelae that occur in patients undergoing chemotherapy or who have received chemotherapy. These symptoms lead to a degradation of the patients' quality of life and can have a significant social and familial impact. They are most commonly described in solid oncology, particularly in patients with breast cancer. Data about patients with hematological maligna...